Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

NCT01176240 is registered in ClinicalTrials.gov with Chelsea Therapeutics as lead sponsor.

NCT NCT01176240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01176240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Lead sponsor
Chelsea Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2010
Completion date
November 30, 2012
Enrollment
225 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

orthostatic hypotension, parkinson's disease